Catalyst Wire Dossier Catalyst Wire Dossier

tirbanibulin ointment 1%

tirbanibulin · Almirall, S.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for tirbanibulin ointment 1%, covering 2024-01-23 to 2024-01-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Tirbanibulin Ointment 1% in Adult Participants With Actinic Keratosis [Phase 3]

See pricing